Aeolus Financial Statements From 2010 to 2024
| AOLS Stock | USD 0.0001 0.00 0.00% |
Check Aeolus Pharmaceuticl financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aeolus Pharmaceuticl's main balance sheet or income statement drivers, such as , as well as many indicators such as . Aeolus financial statements analysis is a perfect complement when working with Aeolus Pharmaceuticl Valuation or Volatility modules.
Aeolus |
Aeolus Pharmaceuticl Company Shares Outstanding Analysis
Aeolus Pharmaceuticl's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Aeolus Pharmaceuticl Shares Outstanding | 152.09 M |
Most of Aeolus Pharmaceuticl's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aeolus Pharmaceuticl is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Aeolus Pharmaceuticl has 152.09 M of shares currently outstending. This is 15.76% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 73.4% higher than that of the company.
Aeolus Pharmaceuticl Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aeolus Pharmaceuticl's current stock value. Our valuation model uses many indicators to compare Aeolus Pharmaceuticl value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aeolus Pharmaceuticl competition to find correlations between indicators driving Aeolus Pharmaceuticl's intrinsic value. More Info.Aeolus Pharmaceuticl is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aeolus Pharmaceuticl's earnings, one of the primary drivers of an investment's value.About Aeolus Pharmaceuticl Financial Statements
Aeolus Pharmaceuticl shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Aeolus Pharmaceuticl investors may analyze each financial statement separately, they are all interrelated. The changes in Aeolus Pharmaceuticl's assets and liabilities, for example, are also reflected in the revenues and expenses on on Aeolus Pharmaceuticl's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California. Aeolus Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aeolus Pink Sheet Analysis
When running Aeolus Pharmaceuticl's price analysis, check to measure Aeolus Pharmaceuticl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aeolus Pharmaceuticl is operating at the current time. Most of Aeolus Pharmaceuticl's value examination focuses on studying past and present price action to predict the probability of Aeolus Pharmaceuticl's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aeolus Pharmaceuticl's price. Additionally, you may evaluate how the addition of Aeolus Pharmaceuticl to your portfolios can decrease your overall portfolio volatility.